Azobenzene derivatives with activity against drug-resistant Candida albicans and Candida auris

被引:4
作者
Raschig, Martina [1 ]
Ramirez-Zavala, Bernardo [2 ]
Wiest, Johannes [1 ]
Saedtler, Marco [1 ]
Gutmann, Marcus [1 ]
Holzgrabe, Ulrike [1 ]
Morschhauser, Joachim [2 ]
Meinel, Lorenz [1 ,3 ]
机构
[1] Univ Wurzburg, Inst Pharm & Food Chem, DE-97074 Wurzburg, Germany
[2] Univ Wurzburg, Inst Mol Infect Biol IMIB, Wurzburg, Germany
[3] Helmholtz Inst RNA Based Infect Biol HIRI, Wurzburg, Germany
关键词
antifungal drug; azobenzenes; Candida albicans; Candida auris; FLUCONAZOLE RESISTANCE; ANTIFUNGAL ACTIVITY; AZO-COMPOUND; EPIDEMIOLOGY; RESVERATROL; INFECTIONS;
D O I
10.1002/ardp.202200463
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Increasing resistance against antimycotic drugs challenges anti-infective therapies today and contributes to the mortality of infections by drug-resistant Candida species and strains. Therefore, novel antifungal agents are needed. A promising approach in developing new drugs is using naturally occurring molecules as lead structures. In this work, 4,4'-dihydroxyazobenzene, a compound structurally related to antifungal stilbene derivatives and present in Agaricus xanthodermus (yellow stainer), served as a starting point for the synthesis of five azobenzene derivatives. These compounds prevented the growth of both fluconazole-susceptible and fluconazole-resistant Candida albicans and Candida auris strains. Further in vivo studies are required to confirm the potential therapeutic value of these compounds.
引用
收藏
页数:7
相关论文
共 29 条
[1]   Epidemiology of invasive candidiasis [J].
Arendrup, Maiken C. .
CURRENT OPINION IN CRITICAL CARE, 2010, 16 (05) :445-452
[2]   Synthesis and characterization of azobenzene derivatives and azobenzene-imidazolium conjugates with selective antimicrobial potential [J].
Babamale, Halimah Funmilayo ;
Sangeetha, Thiagarajan ;
Tan, Joo Shun ;
Yam, WanSinn .
JOURNAL OF MOLECULAR STRUCTURE, 2021, 1232
[3]   Surface and biocidal activity of some synthesized metallo azobenzene isothiouronium salts [J].
Badawi, A. M. ;
Azzam, E. M. S. ;
Morsy, S. M. I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) :8661-8665
[4]   Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008-2013: Results from Population-Based Surveillance [J].
Cleveland, Angela Ahlquist ;
Harrison, Lee H. ;
Farley, Monica M. ;
Hollick, Rosemary ;
Stein, Betsy ;
Chiller, Tom M. ;
Lockhart, Shawn R. ;
Park, Benjamin J. .
PLOS ONE, 2015, 10 (03)
[5]   Structure Modification of an Active Azo-Compound as a Route to New Antimicrobial Compounds [J].
Concilio, Simona ;
Sessa, Lucia ;
Petrone, Anna Maria ;
Porta, Amalia ;
Diana, Rosita ;
Iannelli, Pio ;
Piotto, Stefano .
MOLECULES, 2017, 22 (06)
[6]   Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris [J].
Cortegiani, Andrea ;
Misseri, Giovanni ;
Fasciana, Teresa ;
Giammanco, Anna ;
Giarratano, Antonino ;
Chowdhary, Anuradha .
JOURNAL OF INTENSIVE CARE, 2018, 6
[7]   Azobenzene as Antimicrobial Molecules [J].
Di Martino, Miriam ;
Sessa, Lucia ;
Di Matteo, Martina ;
Panunzi, Barbara ;
Piotto, Stefano ;
Concilio, Simona .
MOLECULES, 2022, 27 (17)
[8]   Epidemiology of Candida species infections in critically ill non-immunosuppressed patients [J].
Eggimann, P ;
Garbino, J ;
Pittet, D .
LANCET INFECTIOUS DISEASES, 2003, 3 (11) :685-702
[9]  
GILL M, 1984, Z NATURFORSCH C, V39, P1027
[10]   ISOLATION OF THE CANDIDA-ALBICANS GENE FOR OROTIDINE-5'-PHOSPHATE DECARBOXYLASE BY COMPLEMENTATION OF S-CEREVISIAE URA3 AND ESCHERICHIA-COLI PYRF MUTATIONS [J].
GILLUM, AM ;
TSAY, EYH ;
KIRSCH, DR .
MOLECULAR & GENERAL GENETICS, 1984, 198 (01) :179-182